In vitro analysis of class switch recombination in mice is challenging due to cytophilic IgE molecules bound to Fc receptors on the surface of B cells. We describe a method for IgE detection using trypsin-mediated cleavage of surface-bound IgE prior to fixation and permeabilization for cytoplasmic fluorescence staining.
B lymphocyte immunoglobulin heavy chain (IgH) class switch recombination (CSR) is a process wherein initially expressed IgM switches to other IgH isotypes, such as IgA, IgE and IgG. Measurement of IgH CSR in vitro is a key method for the study of a number of biologic processes ranging from DNA recombination and repair to aspects of molecular and cellular immunology. In vitro CSR assay involves the flow cytometric measurement surface Ig expression on activated B cells. While measurement of IgA and IgG subclasses is straightforward, measurement of IgE by this method is problematic due to soluble IgE binding to FcεRII/CD23 expressed on the surface of activated B cells. Here we describe a unique procedure for accurate measurement of IgE-producing mouse B cells that have undergone CSR in culture. The method is based on trypsin-mediated cleavage of IgE-CD23 complexes on cell surfaces, allowing for detection of IgE-producing B lineage cells by cytoplasmic staining. This procedure offers a convenient solution for flow cytometric analysis of CSR to IgE.
During immunoglobulin heavy chain (IgH) class switch recombination (CSR) in mice and humans, the IgH μ constant region exons (Cμ) are deleted and replaced by one of several sets of downstream constant region exons (CHs) (e.g. Cγ, Cε, and Cα), resulting in a switch from the production of IgM to the production of other Ig classes (e.g. IgG, IgE, or IgA). CSR occurs within switch (S) regions, which are 1-10 kb sequences located 5’ to each set of CHs1. The Activation-Induced Cytidine Deaminase (AID) enzyme initiates CSR via cytidine deamination activity.
IgE is a key mediator of allergic disease2 and a greater understanding of how IgE is produced and regulated may open doors to new therapeutic approaches to atopic disease. In mice and humans, IgE is the most tightly regulated Ig isotype. IgE is normally detected at levels thousands of times less than other IgH isotypes3, but can be highly elevated in disease states4. However, CSR to IgE is incompletely understood. In vitro activation of B cells using IL-4 in combination with either anti-CD40 or LPS, induces CSR to both IgG1 and IgE5. Activated B cells express the low affinity IgE receptor FcεRII/CD232,6, which binds soluble IgE secreted in culture after CSR. Therefore when analyzing with flow cytometry, B cells with receptor-bound IgE stain similarly to B cells endogenously expressing IgE7. While it is known that mouse B cells express the low affinity IgG receptor FcγRIIB1 (CD32)8, in our experience it does not appear to interfere with measurement of class switching to IgG1. However, when measuring IgE switching after B cell activation in culture, nonspecific surface-bound IgE may obscure the analysis. With common staining methods, non-IgE-expressing cells stain positively for IgE.
Outlined here is a strategy that has been utilized to conduct CSR assays and detect true IgE-expressing B cells from mice9–11. Treatment of activated B cells with trypsin, a common lab reagent to digest protein, removes both cytophylic and membrane bound surface IgE. Subsequent permeabilization and staining for cytoplasmic IgE thus reveals the true IgE-producing cells.
NOTE: All experiments described here were in accordance with The Institutional Animal Care and Use Committee (IACUC) guidelines and approved by Animal Research Children’s Hospital (ARCH), Boston, Mass.
1. Preparation of Reagents
2. Purification and Activation of B Cells
3. Trypsinization, Fixation, and Permeabilization
4. Fluorescence Staining for IgG1 and IgE Class Switching
5. Use the Following Gating Strategy:
This procedure has been successfully implemented to study CSR to IgE in mouse B cells. To demonstrate the efficiency in measuring CSR, we stimulated mouse splenic B cells with anti-CD40 and IL-4 as described previously11. After five days of stimulation, cells were collected and processed using the protocol described above and stained with fluorescently-labeled IgM, IgG1, IgE, and B220 (CD45R) antibodies. Gated on the blasting lymphocytes (Figure 1), a clear population of IgE+ cells cannot be cleanly discriminated without trypsin treatment (Figure 2a). However, trypsinization of cells prior to fixation and permeabilization enables separation of the IgE-producing cells (Figure 2b) due to the removal of surface-bound IgE.
Figure 1: Forward vs. side scatter FACS plot of mouse splenic B cells after 5 days of stimulation in culture with IL-4 and anti-CD40. Blasting lymphocytes make up 63% of the total acquired events.
Figure 2: Effect of trypsin on cytoplasmic staining of IgE and IgG1 in activated B cells. (a, b) FACS plots (above) and histograms (below) gated on blasting splenic B cells from 129/B6 mixed background mice after activation in culture for 5 days with anti-CD40 and IL-4. Fixation and methanol permeabilization alone (a) and with addition of trypsin (b) are shown.
Stimulation of mouse splenic B cells in culture with anti-CD40 and IL-4 will simulate T helper type 2 (TH2) interactions, encouraging class switching to IgG1 and IgE5. B cells can be activated for CSR in the context of total splenocytes12 or as purified splenic B cells11. As noted in the protocol (step 2.3), B cell enrichment is optional, and is at the discretion of the experimenter to determine if it would beneficial. Positive magnetic separation of B cells using CD45R(B220)-labeled beads is utilized here. After separation, it is recommended to check the cell purity by FACS so that the B cell concentration can be adjusted to 1.0 x 106 cells/ml for proper cytokine and antibody stimulation. Also it should be noted that IL-4 protein that has undergone freeze/thaw cycles might have decreased activity.
Trypsinization of cells prior to fixation and permeabilization allows for the accurate measurement of class switching via flow cytometry (Figure 2). Proper trypsinization of the cells is vital to the successful application of this procedure. As FCS can inhibit trypsin, a 1x PBS wash is performed prior to the trypsinization step. We found a 30 sec incubation at room temperature is sufficient for complete digestion. Longer durations can noticeably affect cell viability.
Prior to analysis, it is essential to wash the cells multiple times with PBS to remove traces methanol. Methanol carryover may alter antibody binding13 and can precipitate proteins from FCS used in downstream flow cytometric analysis14. In this regard, other permeabilization methods (i.e. saponin) may be an alternative to using methanol. Methanol is an organic solvent that dissolves membrane lipids, while detergents disrupt membrane integrity15. A benefit to methanol permeabilization is the ability of extended storage of fixed cells at -20 °C14.
There are some limitations to keep in mind when using this procedure. Because trypsin cleaves protein residues, some FACS stains may appear different after treatment, or may lose the ability to bind to target epitopes altogether. Additionally, a loss in cell number after trypsin treatment can occur. However, this does not appear to affect the accuracy of IgE CSR measurements as we have found this method to be clearly comparable to class switching data collected from measuring the antibody secretions of individual hybridoma clones11.
Other methods have been reported to detect IgE-producing mouse B cells. One method uses an acid wash procedure to remove receptor-bound IgE prior to staining for membrane-bound IgE on IgE-expressing cells16–18. Another method uses a monoclonal anti-IgE antibody to block all surface IgE before cell permeabilization and staining for intracellular IgE of the IgE-expressing cells19. Furthermore, a recent study profiled an eight-color FACS panel to identify IgE-switched B cell populations in humans by excluding IgM+, IgD+, IgG+ and IgA+ B cell subsets20. Compared to these other methods, the method described here avoids the use of denaturing acid washes, and excess antibodies are not necessary.
A benefit to this procedure is that it does not prescribe specific monoclonal antibodies for measurement of CSR to IgE. Alternative anti-IgE monoclonal antibodies have been shown to detect only endogenous IgE molecules. The hybridoma clone R1E4 produces a rat-anti-mouse monoclonal IgE antibody specific only for endogenous surface molecules, not cytophilic IgE bound to CD2321,22, but is not commercially available. The protocol described above is convenient and economical because it uses common lab reagents. The anti-IgE antibody used here likely binds to receptor-bound IgE at a site sensitive to trypsin-mediated cleavage, because the IgE signal due to cytophilic IgE is reduced after treatment (Figure 2). However researchers executing this protocol have the freedom to select from a range of commercially available clones for experiments. Furthermore, the concept of using trypsin to remove cell surface proteins can be extended to the detection of other cell markers by FACS analysis.
The authors have nothing to disclose.
D.R.W. is supported by NIH grants AI089972 and AI113217, and by the Mucosal Immunology Studies Team, and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund.
Name | Company | Catalog Number | Comments |
Anti-Mouse IgE FITC | BD Pharmingen | 553415 | clone R35-72 |
Rat Anti-Mouse IgG1 PE | BD Pharmingen | 550083 | clone A85-1 |
Methanol | BDH | BDH1135-4LP | Keep at -20 °C |
Falcon Cell Strainer 40 µm Nylon | Corning | 352340 | |
Falcon Cell Strainer 70 µm Nylon | Corning | 352350 | |
Anti-Hu/Mo CD45R(B220) PerCP-Cy5.5 | eBioscience | 45-4052-82 | clone RA3-6B2 |
anti-Mouse/Rat CD40 | eBioscience | 16-0402-85 | clone HM40-3 |
RPMI Medium 1640 | Gibco | 11875-093 | |
HEPES (1M) | Gibco | 15630-080 | |
MEM-NEAA (100X) | Gibco | 11140-050 | |
Phosphate Buffered Saline (10X) | Lifetechnologies (Corning) | 46-013-CM | |
MACS CD45R (B220) microbeads | Miltenyi Biotec | 130-049-501 | |
MACS purification column | Miltenyi Biotec | 130-042-401 | |
IL-4 | PeproTech | 214-14 | Reconstitute in water or 0.1% BSA |
Formalin Solution, Neutral Buffered, 10% | Sigma Aldrich | HT501128-4L | |
Trypsin-EDTA Solution (10X) | Sigma Aldrich | T4174-100mL | 5.0g Trypsin, 2.0g EDTAŸ4Na per Liter of 0.9% NaCl |
Penicillin-Streptomycin | Sigma Aldrich | P0781-100mL | 10,000U Penicillin; 10 mg/mL Streptomycin (100X) |
L-Glutamine 200mM | Sigma Aldrich | G7513 | |
2-mercaptoethanol (99%) | Sigma Aldrich | M6250-100mL | |
Red cell lysis buffer | Sigma Aldrich | R7757 | |
Rat Anti-Mouse IgM RPE/cy7 | SouthernBiotech | 1140-17 | clone 1B4B1 |
HyClone Fetal Calf Serum | Thermo | SH30910.03 | |
B cell Stimulation media | B cell stimulation media consists of RPMI with fetal calf serum (15%), 20 mM HEPES, 1X MEM-NEAA, 2.0mM L-glutamine, 1X Penicillin-Streptomycin (Penicillin:100 U/ml, Streptomycin: 100 µg/ml), Beta-mercaptoethanol (7 µL/L), IL-4 (20 ng/mL), and anti-CD40 (1 µg/mL) |